Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases

BACKGROUND: The study aims to evaluate the clinical efficacy and safety of bevacizumab in combination with the first-line pemetrexed-platinum (PP) in patients with advanced adenocarcinoma non-small-cell lung cancer (NSCLC) and brain metastases. METHODS: The clinical data of patients with adenocarcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yaru, Zhai, Xiaoyang, Tian, Hairong, Jing, Wang, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890207/
https://www.ncbi.nlm.nih.gov/pubmed/31819641
http://dx.doi.org/10.2147/CMAR.S222910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890207/
https://www.ncbi.nlm.nih.gov/pubmed/31819641
http://dx.doi.org/10.2147/CMAR.S222910

Ejemplares similares